Global Metabolic Disorders Drugs Market Professional Survey Report 2018

Published: Jun, 2018 | Pages: 116 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report studies Metabolic Disorders Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

•	Zealand Pharma
•	Rhythm
•	OxThera
•	Biophytis
•	Biophytis
•	Zafgen
•	PerkinElmer
•	Eternygen
•	Pronutria Biosciences
•	MedGenome
•	CellCentric
•	Nimbus Therapeutics
•	Mitobridge
•	Exelixis, Inc.
•	Outpost Medicine
•	Anchor Therapeutics
•	Verva Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

•	Tablet
•	Injection

By Application, the market can be split into

•	Diabetes
•	Disorders of the Thyroid and Pituitary Gland
•	Other

By Regions, this report covers (we can add the regions/countries as you want)

•	North America
•	China
•	Europe
•	Southeast Asia
•	Japan
•	India

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Global Metabolic Disorders Drugs Market Professional Survey Report 2018

1 Industry Overview of Metabolic Disorders Drugs
    1.1 Definition and Specifications of Metabolic Disorders Drugs
        1.1.1 Definition of Metabolic Disorders Drugs
        1.1.2 Specifications of Metabolic Disorders Drugs
    1.2 Classification of Metabolic Disorders Drugs
        1.2.1 Tablet
        1.2.2 Injection
    1.3 Applications of Metabolic Disorders Drugs
        1.3.1 Diabetes
        1.3.2 Disorders of the Thyroid and Pituitary Gland
        1.3.3 Other
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Metabolic Disorders Drugs
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Metabolic Disorders Drugs
    2.3 Manufacturing Process Analysis of Metabolic Disorders Drugs
    2.4 Industry Chain Structure of Metabolic Disorders Drugs

3 Technical Data and Manufacturing Plants Analysis of Metabolic Disorders Drugs
    3.1 Capacity and Commercial Production Date of Global Metabolic Disorders Drugs Major Manufacturers in 2017
    3.2 Manufacturing Plants Distribution of Global Metabolic Disorders Drugs Major Manufacturers in 2017
    3.3 R&D Status and Technology Source of Global Metabolic Disorders Drugs Major Manufacturers in 2017
    3.4 Raw Materials Sources Analysis of Global Metabolic Disorders Drugs Major Manufacturers in 2017

4 Global Metabolic Disorders Drugs Overall Market Overview
    4.1 2013-2018E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2013-2018E Global Metabolic Disorders Drugs Capacity and Growth Rate Analysis
        4.2.2 2017 Metabolic Disorders Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2013-2018E Global Metabolic Disorders Drugs Sales and Growth Rate Analysis
        4.3.2 2017 Metabolic Disorders Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2013-2018E Global Metabolic Disorders Drugs Sales Price
        4.4.2 2017 Metabolic Disorders Drugs Sales Price Analysis (Company Segment)

5 Metabolic Disorders Drugs Regional Market Analysis
    5.1 North America Metabolic Disorders Drugs Market Analysis
        5.1.1 North America Metabolic Disorders Drugs Market Overview
        5.1.2 North America 2013-2018E Metabolic Disorders Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2013-2018E Metabolic Disorders Drugs Sales Price Analysis
        5.1.4 North America 2017 Metabolic Disorders Drugs Market Share Analysis
    5.2 China Metabolic Disorders Drugs Market Analysis
        5.2.1 China Metabolic Disorders Drugs Market Overview
        5.2.2 China 2013-2018E Metabolic Disorders Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2013-2018E Metabolic Disorders Drugs Sales Price Analysis
        5.2.4 China 2017 Metabolic Disorders Drugs Market Share Analysis
    5.3 Europe Metabolic Disorders Drugs Market Analysis
        5.3.1 Europe Metabolic Disorders Drugs Market Overview
        5.3.2 Europe 2013-2018E Metabolic Disorders Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2013-2018E Metabolic Disorders Drugs Sales Price Analysis
        5.3.4 Europe 2017 Metabolic Disorders Drugs Market Share Analysis
    5.4 Southeast Asia Metabolic Disorders Drugs Market Analysis
        5.4.1 Southeast Asia Metabolic Disorders Drugs Market Overview
        5.4.2 Southeast Asia 2013-2018E Metabolic Disorders Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2013-2018E Metabolic Disorders Drugs Sales Price Analysis
        5.4.4 Southeast Asia 2017 Metabolic Disorders Drugs Market Share Analysis
    5.5 Japan Metabolic Disorders Drugs Market Analysis
        5.5.1 Japan Metabolic Disorders Drugs Market Overview
        5.5.2 Japan 2013-2018E Metabolic Disorders Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2013-2018E Metabolic Disorders Drugs Sales Price Analysis
        5.5.4 Japan 2017 Metabolic Disorders Drugs Market Share Analysis
    5.6 India Metabolic Disorders Drugs Market Analysis
        5.6.1 India Metabolic Disorders Drugs Market Overview
        5.6.2 India 2013-2018E Metabolic Disorders Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2013-2018E Metabolic Disorders Drugs Sales Price Analysis
        5.6.4 India 2017 Metabolic Disorders Drugs Market Share Analysis

6 Global 2013-2018E Metabolic Disorders Drugs Segment Market Analysis (by Type)
    6.1 Global 2013-2018E Metabolic Disorders Drugs Sales by Type
    6.2 Different Types of Metabolic Disorders Drugs Product Interview Price Analysis
    6.3 Different Types of Metabolic Disorders Drugs Product Driving Factors Analysis
        6.3.1 Tablet of Metabolic Disorders Drugs Growth Driving Factor Analysis
        6.3.2 Injection of Metabolic Disorders Drugs Growth Driving Factor Analysis

7 Global 2013-2018E Metabolic Disorders Drugs Segment Market Analysis (by Application)
    7.1 Global 2013-2018E Metabolic Disorders Drugs Consumption by Application
    7.2 Different Application of Metabolic Disorders Drugs Product Interview Price Analysis
    7.3 Different Application of Metabolic Disorders Drugs Product Driving Factors Analysis
        7.3.1 Diabetes of Metabolic Disorders Drugs Growth Driving Factor Analysis
        7.3.2 Disorders of the Thyroid and Pituitary Gland of Metabolic Disorders Drugs Growth Driving Factor Analysis
        7.3.3 Other of Metabolic Disorders Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Metabolic Disorders Drugs
    8.1 Zealand Pharma
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Zealand Pharma 2017 Metabolic Disorders Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Zealand Pharma 2017 Metabolic Disorders Drugs Business Region Distribution Analysis
    8.2 Rhythm
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Rhythm 2017 Metabolic Disorders Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Rhythm 2017 Metabolic Disorders Drugs Business Region Distribution Analysis
    8.3 OxThera
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 OxThera 2017 Metabolic Disorders Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 OxThera 2017 Metabolic Disorders Drugs Business Region Distribution Analysis
    8.4 Biophytis
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Biophytis 2017 Metabolic Disorders Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Biophytis 2017 Metabolic Disorders Drugs Business Region Distribution Analysis
    8.5 Biophytis
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Biophytis 2017 Metabolic Disorders Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Biophytis 2017 Metabolic Disorders Drugs Business Region Distribution Analysis
    8.6 Zafgen
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Zafgen 2017 Metabolic Disorders Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Zafgen 2017 Metabolic Disorders Drugs Business Region Distribution Analysis
    8.7 PerkinElmer
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 PerkinElmer 2017 Metabolic Disorders Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 PerkinElmer 2017 Metabolic Disorders Drugs Business Region Distribution Analysis
    8.8 Eternygen
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Eternygen 2017 Metabolic Disorders Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Eternygen 2017 Metabolic Disorders Drugs Business Region Distribution Analysis
    8.9 Pronutria Biosciences
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Pronutria Biosciences 2017 Metabolic Disorders Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Pronutria Biosciences 2017 Metabolic Disorders Drugs Business Region Distribution Analysis
    8.10 MedGenome
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 MedGenome 2017 Metabolic Disorders Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 MedGenome 2017 Metabolic Disorders Drugs Business Region Distribution Analysis
    8.11 CellCentric
    8.12 Nimbus Therapeutics
    8.13 Mitobridge
    8.14 Exelixis, Inc.
    8.15 Outpost Medicine
    8.16 Anchor Therapeutics
    8.17 Verva Pharmaceuticals

9 Development Trend of Analysis of Metabolic Disorders Drugs Market
    9.1 Global Metabolic Disorders Drugs Market Trend Analysis
        9.1.1 Global 2018-2025 Metabolic Disorders Drugs Market Size (Volume and Value) Forecast
        9.1.2 Global 2018-2025 Metabolic Disorders Drugs Sales Price Forecast
    9.2 Metabolic Disorders Drugs Regional Market Trend
        9.2.1 North America 2018-2025 Metabolic Disorders Drugs Consumption Forecast
        9.2.2 China 2018-2025 Metabolic Disorders Drugs Consumption Forecast
        9.2.3 Europe 2018-2025 Metabolic Disorders Drugs Consumption Forecast
        9.2.4 Southeast Asia 2018-2025 Metabolic Disorders Drugs Consumption Forecast
        9.2.5 Japan 2018-2025 Metabolic Disorders Drugs Consumption Forecast
        9.2.6 India 2018-2025 Metabolic Disorders Drugs Consumption Forecast
    9.3 Metabolic Disorders Drugs Market Trend (Product Type)
    9.4 Metabolic Disorders Drugs Market Trend (Application)

10 Metabolic Disorders Drugs Marketing Type Analysis
    10.1 Metabolic Disorders Drugs Regional Marketing Type Analysis
    10.2 Metabolic Disorders Drugs International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Metabolic Disorders Drugs by Region
    10.4 Metabolic Disorders Drugs Supply Chain Analysis

11 Consumers Analysis of Metabolic Disorders Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Metabolic Disorders Drugs Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures
    
Figure Picture of Metabolic Disorders Drugs
    Table Product Specifications of Metabolic Disorders Drugs
    Table Classification of Metabolic Disorders Drugs
    Figure Global Production Market Share of Metabolic Disorders Drugs by Type in 2017
    Figure Tablet Picture
    Table Major Manufacturers of Tablet
    Figure Injection Picture
    Table Major Manufacturers of Injection
    Table Applications of Metabolic Disorders Drugs
    Figure Global Consumption Volume Market Share of Metabolic Disorders Drugs by Application in 2017
    Figure Diabetes Examples
    Table Major Consumers in Diabetes
    Figure Disorders of the Thyroid and Pituitary Gland Examples
    Table Major Consumers in Disorders of the Thyroid and Pituitary Gland
    Figure Other Examples
    Table Major Consumers in Other
    Figure Market Share of Metabolic Disorders Drugs by Regions
    Figure North America Metabolic Disorders Drugs Market Size (Million USD) (2013-2025)
    Figure China Metabolic Disorders Drugs Market Size (Million USD) (2013-2025)
    Figure Europe Metabolic Disorders Drugs Market Size (Million USD) (2013-2025)
    Figure Southeast Asia Metabolic Disorders Drugs Market Size (Million USD) (2013-2025)
    Figure Japan Metabolic Disorders Drugs Market Size (Million USD) (2013-2025)
    Figure India Metabolic Disorders Drugs Market Size (Million USD) (2013-2025)
    Table Metabolic Disorders Drugs Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Metabolic Disorders Drugs in 2017
    Figure Manufacturing Process Analysis of Metabolic Disorders Drugs
    Figure Industry Chain Structure of Metabolic Disorders Drugs
    Table Capacity and Commercial Production Date of Global Metabolic Disorders Drugs Major Manufacturers in 2017
    Table Manufacturing Plants Distribution of Global Metabolic Disorders Drugs Major Manufacturers in 2017
    Table R&D Status and Technology Source of Global Metabolic Disorders Drugs Major Manufacturers in 2017
    Table Raw Materials Sources Analysis of Global Metabolic Disorders Drugs Major Manufacturers in 2017
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Metabolic Disorders Drugs 2013-2018E
    Figure Global 2013-2018E Metabolic Disorders Drugs Market Size (Volume) and Growth Rate
    Figure Global 2013-2018E Metabolic Disorders Drugs Market Size (Value) and Growth Rate
    Table 2013-2018E Global Metabolic Disorders Drugs Capacity and Growth Rate
    Table 2017 Global Metabolic Disorders Drugs Capacity (K Units) List (Company Segment)
    Table 2013-2018E Global Metabolic Disorders Drugs Sales (K Units) and Growth Rate
    Table 2017 Global Metabolic Disorders Drugs Sales (K Units) List (Company Segment)
    Table 2013-2018E Global Metabolic Disorders Drugs Sales Price (USD/Unit)
    Table 2017 Global Metabolic Disorders Drugs Sales Price (USD/Unit) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Units) of Metabolic Disorders Drugs 2013-2018E 
    Figure North America 2013-2018E Metabolic Disorders Drugs Sales Price (USD/Unit)
    Figure North America 2017 Metabolic Disorders Drugs Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Units) of Metabolic Disorders Drugs 2013-2018E 
    Figure China 2013-2018E Metabolic Disorders Drugs Sales Price (USD/Unit) 
    Figure China 2017 Metabolic Disorders Drugs Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Units) of Metabolic Disorders Drugs 2013-2018E
    Figure Europe 2013-2018E Metabolic Disorders Drugs Sales Price (USD/Unit)
    Figure Europe 2017 Metabolic Disorders Drugs Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Metabolic Disorders Drugs 2013-2018E
    Figure Southeast Asia 2013-2018E Metabolic Disorders Drugs Sales Price (USD/Unit)
    Figure Southeast Asia 2017 Metabolic Disorders Drugs Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Units) of Metabolic Disorders Drugs 2013-2018E
    Figure Japan 2013-2018E Metabolic Disorders Drugs Sales Price (USD/Unit)
    Figure Japan 2017 Metabolic Disorders Drugs Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Units) of Metabolic Disorders Drugs 2013-2018E
    Figure India 2013-2018E Metabolic Disorders Drugs Sales Price (USD/Unit)
    Figure India 2017 Metabolic Disorders Drugs Sales Market Share
    Table Global 2013-2018E Metabolic Disorders Drugs Sales (K Units) by Type
    Table Different Types Metabolic Disorders Drugs Product Interview Price
    Table Global 2013-2018E Metabolic Disorders Drugs Sales (K Units) by Application
    Table Different Application Metabolic Disorders Drugs Product Interview Price
    Table Zealand Pharma Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Zealand Pharma Metabolic Disorders Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Zealand Pharma Metabolic Disorders Drugs Business Region Distribution
    Table Rhythm Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Rhythm Metabolic Disorders Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Rhythm Metabolic Disorders Drugs Business Region Distribution
    Table OxThera Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 OxThera Metabolic Disorders Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 OxThera Metabolic Disorders Drugs Business Region Distribution
    Table Biophytis Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Biophytis Metabolic Disorders Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Biophytis Metabolic Disorders Drugs Business Region Distribution
    Table Biophytis Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Biophytis Metabolic Disorders Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Biophytis Metabolic Disorders Drugs Business Region Distribution
    Table Zafgen Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Zafgen Metabolic Disorders Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Zafgen Metabolic Disorders Drugs Business Region Distribution
    Table PerkinElmer Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 PerkinElmer Metabolic Disorders Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 PerkinElmer Metabolic Disorders Drugs Business Region Distribution
    Table Eternygen Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Eternygen Metabolic Disorders Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Eternygen Metabolic Disorders Drugs Business Region Distribution
    Table Pronutria Biosciences Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Pronutria Biosciences Metabolic Disorders Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Pronutria Biosciences Metabolic Disorders Drugs Business Region Distribution
    Table MedGenome Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 MedGenome Metabolic Disorders Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 MedGenome Metabolic Disorders Drugs Business Region Distribution
    Table CellCentric Information List
    Table Nimbus Therapeutics Information List
    Table Mitobridge Information List
    Table Exelixis, Inc. Information List
    Table Outpost Medicine Information List
    Table Anchor Therapeutics Information List
    Table Verva Pharmaceuticals Information List
    Figure Global 2018-2025 Metabolic Disorders Drugs Market Size (K Units) and Growth Rate Forecast
    Figure Global 2018-2025 Metabolic Disorders Drugs Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2018-2025 Metabolic Disorders Drugs Sales Price (USD/Unit) Forecast
    Figure North America 2018-2025 Metabolic Disorders Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure China 2018-2025 Metabolic Disorders Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure Europe 2018-2025 Metabolic Disorders Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure Southeast Asia 2018-2025 Metabolic Disorders Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure Japan 2018-2025 Metabolic Disorders Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure India 2018-2025 Metabolic Disorders Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Table Global Sales Volume (K Units) of Metabolic Disorders Drugs by Type 2018-2025
    Table Global Consumption Volume (K Units) of Metabolic Disorders Drugs by Application 2018-2025
    Table Traders or Distributors with Contact Information of Metabolic Disorders Drugs by Region